AKT1 and ovarian carcinoma: Dimple et al. [41] suggested that PELP1 downregulation reduces the proliferation and tumorigenic potential of ovarian cancer cells and affects the magnitude of c-Src and protein kinase B (AKT) signaling in a nude mouse model.